thiazoles has been researched along with Torsade de Pointes in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Kambayashi, R; Matsumoto, A; Naito, AT; Sugiyama, A | 1 |
Alipour, A; Cruz, R; Lott, RS | 1 |
Correll, CU; Figen, V; Kane, JM; Lops, JD; Malhotra, AK; Manu, P | 1 |
Nielsen, J | 1 |
Taylor, D | 1 |
Martel, ML | 1 |
Citrome, L; Volavka, J | 1 |
Finzel, M; Fric, M; Laux, G | 1 |
Brown, FW; Greco, KE; Tune, LE; Van Horn, WA | 1 |
Hoffman, RS; Manini, AF; Nelson, LS; Raspberry, D | 1 |
2 review(s) available for thiazoles and Torsade de Pointes
Article | Year |
---|---|
Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes | 2003 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
1 trial(s) available for thiazoles and Torsade de Pointes
Article | Year |
---|---|
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
Topics: Antipsychotic Agents; Electrocardiography; Germany; Hospitalization; Hospitals, Psychiatric; Humans; Long QT Syndrome; Piperazines; Prospective Studies; Psychotic Disorders; Risk Assessment; Thiazoles; Torsades de Pointes | 2004 |
7 other study(ies) available for thiazoles and Torsade de Pointes
Article | Year |
---|---|
Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium.
Topics: Action Potentials; Anesthetics, Inhalation; Animals; Calcium Channel Agonists; Cardiac Conduction System Disease; Delirium; Dogs; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrocardiography; Female; Halothane; Heart Conduction System; Humans; Isoindoles; Long QT Syndrome; Middle Aged; Models, Animal; Piperazines; Piperidines; Potassium Channel Blockers; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Thiazoles; Torsades de Pointes | 2020 |
Torsade de pointes after ziprasidone overdose with coingestants.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes | 2010 |
QT interval duration and dispersion in children and adolescents treated with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Piperazines; Potassium; Thiazoles; Torsades de Pointes | 2011 |
The safety of atypical antipsychotics: does QTc provide all the answers?
Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Piperazines; Thiazoles; Torsades de Pointes | 2011 |
Ziprasidone for sedation of the agitated ED patient.
Topics: Antipsychotic Agents; Droperidol; Drug Labeling; Emergency Treatment; Humans; Long QT Syndrome; Piperazines; Practice Guidelines as Topic; Psychomotor Agitation; Thiazoles; Torsades de Pointes; United States; United States Food and Drug Administration | 2004 |
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Retrospective Studies; Risk Factors; Thiazoles; Torsades de Pointes | 2005 |
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Antipsychotic Agents; Drug Overdose; Drug Therapy, Combination; Electrocardiography; Fatal Outcome; Female; Humans; Ibuprofen; Long QT Syndrome; Piperazines; Suicide, Attempted; Thiazoles; Torsades de Pointes | 2007 |